The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Use Of Landiolol Hydrochloride In The Long-Term Treatment Of Tachyarrhythmias - EP2988750

The patent EP2988750 was granted to AOP Orphan Pharmaceuticals on Sep 17, 2025. The application was originally filed on Apr 25, 2014 under application number EP14720107A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2988750

AOP ORPHAN PHARMACEUTICALS
Application Number
EP14720107A
Filing Date
Apr 25, 2014
Status
Patent Maintained As Amended
Apr 25, 2025
Publication Date
Sep 17, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BECKEROct 18, 2022BECKER KURIG & PARTNER PATENTANWALTE MBBADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONCN1827109
OPPOSITIONEP1652533
OPPOSITIONEP2234614
OPPOSITIONEP2796139
OPPOSITIONWO2014174076

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents